Advanced Heart Failure Management and Selection for Advanced Therapies

View Sample PDF

Author(s): Alexander Papolos (Icahn School of Medicine at Mount Sinai, USA), Nishant A. Gandhi (Icahn School of Medicine at Mount Sinai, USA), Elrond Teo (Emory University Hospital, USA)and Raymond Bietry (Icahn School of Medicine at Mount Sinai, USA)
Copyright: 2015
Pages: 20
Source title: Modern Concepts and Practices in Cardiothoracic Critical Care
Source Author(s)/Editor(s): Adam S. Evans (Icahn School of Medicine at Mount Sinai, USA), Gregory E. Kerr (Weill Cornell Medical College, USA), Insung Chung (Icahn School of Medicine at Mount Sinai, USA)and Robin Varghese (Icahn School of Medicine at Mount Sinai, USA)
DOI: 10.4018/978-1-4666-8603-8.ch009

Keywords: Cardiovascular Medicine / Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare

Purchase

View Advanced Heart Failure Management and Selection for Advanced Therapies on the publisher's website for pricing and purchasing information.

Abstract

Advancements in the field of heart failure have significantly improved both mortality and the quality of life of millions. However, heart failure generally remains a chronic disease with an insidious progression to organ failure despite optimal medical treatment. Early consideration of advanced therapies such as mechanical circulatory support and cardiac transplantation in advanced heart failure is essential. The purpose of this chapter is to assist the reader in the identification of patients with advanced heart failure that have not yet developed irreversible end-organ dysfunction, as interventions in this narrow therapeutic window results in improved post-surgical outcomes.

The IRMA Community

Research IRM

Advanced Heart Failure Management and Selection for Advanced Therapies

Purchase

Abstract

Related Content

IRMA Sponsors